Cellular senescence is associated with the spatial evolution toward a higher metastatic phenotype in colorectal cancer

Cell Rep. 2024 Mar 26;43(3):113912. doi: 10.1016/j.celrep.2024.113912. Epub 2024 Mar 6.

Abstract

In this study, we explore the dynamic process of colorectal cancer progression, emphasizing the evolution toward a more metastatic phenotype. The term "evolution" as used in this study specifically denotes the phenotypic transition toward a higher metastatic potency from well-formed glandular structures to collective invasion, ultimately resulting in the development of cancer cell buddings at the invasive front. Our findings highlight the spatial correlation of this evolution with tumor cell senescence, revealing distinct types of senescent tumor cells (types I and II) that play different roles in the overall cancer progression. Type I senescent tumor cells (p16INK4A+/CXCL12+/LAMC2-/MMP7-) are identified in the collective invasion region, whereas type II senescent tumor cells (p16INK4A+/CXCL12+/LAMC2+/MMP7+), representing the final evolved form, are prominently located in the partial-EMT region. Importantly, type II senescent tumor cells associate with local invasion and lymph node metastasis in colorectal cancer, potentially affecting patient prognosis.

Keywords: CP: Cancer; LAMC2; MMP7; cancer buddings; cancer evolution; collective invasion; colorectal cancer; lymph node metastasis; senescent tumor cells; spatial evolution; spatial transcriptomics.

MeSH terms

  • Cellular Senescence / genetics
  • Colorectal Neoplasms* / genetics
  • Colorectal Neoplasms* / pathology
  • Cyclin-Dependent Kinase Inhibitor p16 / metabolism
  • Humans
  • Matrix Metalloproteinase 7* / genetics
  • Phenotype

Substances

  • Matrix Metalloproteinase 7
  • Cyclin-Dependent Kinase Inhibitor p16